Hepion Pharmaceuticals, Inc. (HEPA) Operating income 2016–2025
Hepion Pharmaceuticals, Inc. (HEPA) annual operating income history from SEC filings — each fiscal year as reported.
-$4.2MFY2025 · since FY2016: -$21.0M → -$4.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.2M | +78.5% |
| FY2024 | -$19.3M | +60.1% |
| FY2023 | -$48.4M | -6.5% |
| FY2022 | -$45.5M | -49.6% |
| FY2021 | -$30.4M | -50.9% |
| FY2020 | -$20.1M | -159.3% |
| FY2019 | -$7.8M | +46.8% |
| FY2018 | -$14.6M | +29.3% |
| FY2017 | -$20.6M | +1.8% |
| FY2016 | -$21.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More HEPA financial trends
HEPA RevenueHEPA Net incomeHEPA Net marginHEPA Gross profitHEPA Gross marginHEPA Operating marginHEPA Operating cash flowHEPA Free cash flowHEPA Capital expendituresHEPA Return on equityHEPA Stock buybacksHEPA Dividends paidHEPA Total assetsHEPA Total liabilitiesHEPA Shareholders’ equityHEPA overview →